Answers are grounded in this paper and cite their sources.
Peripheral blood was collected from healthy volunteers (n=5). Total LMN homogenate expresses H1, H5 and H6 parkin isoforms. These data have been confirmed by immunoprecipitation analysis, by using three antibodies recognizing different domains of the full-length. In human CD2+, CD14+ and CD19+ subpopulations, two bands of ~58 and ~52 kDa molecular weight have been revealed. These proteins are distributed both in cytoplasm and nucleus, as demonstrated by fluorescence immunolocalization. The expression of parkin isoforms in human blood cells is subpopulation-specific, and is likely altered in PD patients. A future investigation of the parkin splicing profile in human blood cells could represent a useful tool for identify early non-invasive biomarkers in patients affected by ARJP.
No takes yet. Share an insight, caveat, or question.
A 2016 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: